AMANDA RODRIGUEZ: Open Payments
NPI 1205503174 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 41 payments from 12 companies in 2025. Trend: 2023 $2,998 · 2024 $319 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 8 | $525 |
| ABBVIE INC. | 9 | $313 |
| GENZYME CORPORATION | 10 | $174 |
| Galderma Laboratories, L.P. | 3 | $141 |
| MERZ NORTH AMERICA, INC. | 1 | $139 |
| Arcutis Biotherapeutics, Inc. | 1 | $113 |
| Innovation Technologies Inc | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 1 | $58 |
| Lilly USA, LLC | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
Products named: DAXXIFY, BOTOX, DUPIXENT, NEMLUVIO, Xeomin, Zoryve, IRRISEPT, EBGLYSS.
Industry payments across LA — which companies pay providers there.
